DEBORAH SOMMERS: Open Payments
NPI 1023004066 · WAKEMAN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 81 payments from 16 companies in 2025. Trend: 2023 $395 · 2024 $970 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $345 |
| Novo Nordisk Inc | 9 | $149 |
| Abbott Laboratories | 5 | $109 |
| PFIZER INC. | 5 | $81 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Lilly USA, LLC | 4 | $70 |
| Exact Sciences Corporation | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 4 | $60 |
| Amgen Inc. | 3 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
Products named: UBRELVY, QULIPTA, FREESTYLE LIBRE 3, MOUNJARO, The Cologuard Plus Collection Kit, Rybelsus, Auvelity, NURTEC ODT.
Industry payments across OH — which companies pay providers there.
